News
-
The 1st TIF Webinar for Medical Specialists Scheduled for 11 May
The 1st webinar for Medical Specialists organised in the context of TIF’s eThalEd online course has just arrived! Dr Antonio Piga, Professor of Paediatrics & Dean of the Medicine School at…
Read More » -
TIF’s Global Call for Solidarity & Cooperation in support of WHO
TIF expresses major concerns over the announcement of the United States to suspend financial support for the World Health Organisation (WHO) until completion of a review of the organisation’s activities related…
Read More » -
COVID-19: TIF Releases Position Statement on the Inclusion of Thalassaemia & SCD Patients in the High-Risk Population
The SARS-CoV-2 infection presents particular challenges and great risks to patients with thalassaemia and sickle cell disease (SCD) and, if their appropriate clinical management as described in International Guidelines is…
Read More » -
TIF and EHA Explore How COVID-19 Is Affecting Thalassemia & SCD Patients
On 16 April, TIF and the European Hematology Association (EHA) successfully organised a highly interactive webinar entitled ”Thalassaemia/SCD and COVID-19: Possible risks and a proposal for a patient pathway during…
Read More » -
NOW ONLINE: TIF’s latest Informational Guide on Developing Vaccinations & Therapeutic Drugs for COVID-19
TIF has made an effort to put together a list of studies/clinical trials for treatments and vaccines about COVID-19, which is by no means exhaustive as this situation is ever-changing…
Read More » -
“Now I Am The Voice“: A journey of self‐discovery through the eyes of a Thalassaemic
TIF’s Expert Patient and long-standing collaborator and friend, Maria Hadjidemetriou, shares her inspiring and thought-provoking journey with thalassaemia and reflects on the lessons it has taught her. Click on the…
Read More » -
JUST LANDED: A new TIF Publication on Blood & COVID-19
Is the new coronavirus transfusion transmittable? What is the guidance that internationally acclaimed bodies, such as the World Health Organisation (WHO), the US Centers for Disease Control and Prevention (CDC)…
Read More » -
Revisiting WHO Guidance Document on the Protection of Blood Supplies developed with TIF’s contribution
In an effort to assist national blood services in the development of plans to respond to any emerging infectious threats, as far as the sufficiency or safety of the…
Read More » -
Novavax to start human trial for ‘ideal’ coronavirus vaccine candidate
The biotech company Novavax announced today that it has identified an “ideal” coronavirus vaccine candidate — and is set to launch the first clinical human trial in mid-May. The candidate,…
Read More » -
WORLD HEALTH DAY: Honouring the work of nurses and midwives – 7 April 2020
Nurses and other health workers are at the frontlines of COVID-19 response, putting their own health at risk to protect the broader community. This World Health Day, the World Health Organisation…
Read More »